{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T06:37:21Z","timestamp":1790836641795,"version":"4.1.0"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2017,12,22]],"date-time":"2017-12-22T00:00:00Z","timestamp":1513900800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"The Ministry of Science, ICT and Future Planning","award":["NRF-2017R1A2B1003346"],"award-info":[{"award-number":["NRF-2017R1A2B1003346"]}]},{"name":"The Ministry of Science, ICT and Future Planning","award":["NRF-2016R1A1A1A05005201"],"award-info":[{"award-number":["NRF-2016R1A1A1A05005201"]}]},{"name":"Korea government (MSIP)","award":["2011-0018355"],"award-info":[{"award-number":["2011-0018355"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1007\/s12035-017-0830-x","type":"journal-article","created":{"date-parts":[[2017,12,21]],"date-time":"2017-12-21T21:10:02Z","timestamp":1513890602000},"page":"6201-6214","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":65,"title":["Trichloroethylene and Parkinson\u2019s Disease: Risk Assessment"],"prefix":"10.1007","volume":"55","author":[{"given":"Mei","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eun-Joo","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duy-Khanh","family":"Dang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-Hui","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phil Ho","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji Hoon","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seok-Joo","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong-Sun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Xing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Xin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoying","family":"Bing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0420-795X","authenticated-orcid":false,"given":"Hyoung-Chun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,12,22]]},"reference":[{"issue":"3","key":"830_CR1","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/0165-1781(79)90006-4","volume":"1","author":"GC Davis","year":"1979","unstructured":"Davis GC, Williams AC, Markey SP, Ebert MH, Caine ED, Reichert CM, Kopin IJ (1979) Chronic parkinsonism secondary to intravenous injection of meperidine analogues. Psychiatry Res 1(3):249\u2013254. \nhttps:\/\/doi.org\/10.1016\/0165-1781(79)90006-4","journal-title":"Psychiatry Res"},{"issue":"14","key":"830_CR2","doi-asserted-by":"publisher","first-page":"4546","DOI":"10.1073\/pnas.80.14.4546","volume":"80","author":"RS Burns","year":"1983","unstructured":"Burns RS, Chiueh CC, Markey SP, Ebert MH, Jacobowitz DM, Kopin IJ (1983) A primate model of parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Proc Natl Acad Sci U S A 80(14):4546\u20134550. \nhttps:\/\/doi.org\/10.1073\/pnas.80.14.4546","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"830_CR3","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1002\/ajim.4700170307","volume":"17","author":"C Hertzman","year":"1990","unstructured":"Hertzman C, Wiens M, Bowering D, Snow B, Calne D (1990) Parkinson\u2019s disease: a case-control study of occupational and environmental risk factors. Am J Ind Med 17(3):349\u2013355. \nhttps:\/\/doi.org\/10.1002\/ajim.4700170307","journal-title":"Am J Ind Med"},{"issue":"6","key":"830_CR4","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1212\/WNL.48.6.1583","volume":"48","author":"HH Liou","year":"1997","unstructured":"Liou HH, Tsai MC, Chen CJ, Jeng JS, Chang YC, Chen SY, Chen RC (1997) Environmental risk factors and Parkinson\u2019s disease: a case-control study in Taiwan. Neurology 48(6):1583\u20131588. \nhttps:\/\/doi.org\/10.1212\/WNL.48.6.1583","journal-title":"Neurology"},{"issue":"2","key":"830_CR5","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S0733-8619(18)30212-3","volume":"10","author":"CM Tanner","year":"1992","unstructured":"Tanner CM (1992) Epidemiology of Parkinson\u2019s disease. Neurol Clin 10(2):317\u2013329","journal-title":"Neurol Clin"},{"issue":"16","key":"830_CR6","doi-asserted-by":"crossref","first-page":"7006","DOI":"10.1523\/JNEUROSCI.22-16-07006.2002","volume":"22","author":"TB Sherer","year":"2002","unstructured":"Sherer TB, Betarbet R, Stout AK, Lund S, Baptista M, Panov AV, Cookson MR, Greenamyre JT (2002) An in vitro model of Parkinson\u2019s disease: linking mitochondrial impairment to altered alpha-synuclein metabolism and oxidative damage. J Neurosci 22(16):7006\u20137015 \n20026721","journal-title":"J Neurosci"},{"issue":"2","key":"830_CR7","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1002\/ana.21288","volume":"63","author":"DM Gash","year":"2008","unstructured":"Gash DM, Rutland K, Hudson NL, Sullivan PG, Bing G, Cass WA, Pandya JD, Liu M et al (2008) Trichloroethylene: parkinsonism and complex 1 mitochondrial neurotoxicity. Ann Neurol 63(2):184\u2013192. \nhttps:\/\/doi.org\/10.1002\/ana.21288","journal-title":"Ann Neurol"},{"issue":"6","key":"830_CR8","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1002\/ana.22629","volume":"71","author":"SM Goldman","year":"2012","unstructured":"Goldman SM, Quinlan PJ, Ross GW, Marras C, Meng C, Bhudhikanok GS, Comyns K, Korell M et al (2012) Solvent exposures and Parkinson disease risk in twins. Ann Neurol 71(6):776\u2013784. \nhttps:\/\/doi.org\/10.1002\/ana.22629","journal-title":"Ann Neurol"},{"issue":"3","key":"830_CR9","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1111\/j.1471-4159.2009.06497.x","volume":"112","author":"M Liu","year":"2010","unstructured":"Liu M, Choi DY, Hunter RL, Pandya JD, Cass WA, Sullivan PG, Kim HC, Gash DM et al (2010) Trichloroethylene induces dopaminergic neurodegeneration in Fischer 344 rats. J Neurochem 112(3):773\u2013783. \nhttps:\/\/doi.org\/10.1111\/j.1471-4159.2009.06497.x","journal-title":"J Neurochem"},{"key":"830_CR10","volume-title":"Assessing the human health risks of trichloroethylene; key scientific issues","author":"National Research Council","year":"2006","unstructured":"National Research Council (2006) Assessing the human health risks of trichloroethylene; key scientific issues. The National Academies Press, Washington"},{"issue":"5","key":"830_CR11","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1046\/j.1468-1331.1999.650609.x","volume":"6","author":"D Guehl","year":"1999","unstructured":"Guehl D, Bezard E, Dovero S, Boraud T, Bioulac B, Gross C (1999) Trichloroethylene and parkinsonism: a human and experimental observation. Eur J Neurol 6(5):609\u2013611. \nhttps:\/\/doi.org\/10.1046\/j.1468-1331.1999.650609.x","journal-title":"Eur J Neurol"},{"key":"830_CR12","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1007\/978-1-4615-0135-0_29","volume":"527","author":"W Kochen","year":"2003","unstructured":"Kochen W, Kohlm\u00fcller D, De Biasi P, Ramsay R (2003) The endogeneous formation of highly chlorinated tetrahydro-beta-carbolines as a possible causative mechanism in idiopathic Parkinson\u2019s disease. Adv Exp Med Biol 527:253\u2013263. \nhttps:\/\/doi.org\/10.1007\/978-1-4615-0135-0_29","journal-title":"Adv Exp Med Biol"},{"key":"830_CR13","first-page":"245","volume":"46","author":"G Bringmann","year":"1995","unstructured":"Bringmann G, God R, Feineis D, Janetzky B, Reichmann H (1995a) TaClo as a neurotoxic lead: improved synthesis, stereochemical analysis, and inhibition of the mitochondrial respiratory chain. J Neural Transm Suppl 46:245\u2013254","journal-title":"J Neural Transm Suppl"},{"issue":"1\u20132","key":"830_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0014-2999(02)01308-0","volume":"442","author":"P Riederer","year":"2002","unstructured":"Riederer P, Foley P, Bringmann G, Feineis D, Br\u00fcckner R, Gerlach M (2002) Biochemical and pharmacological characterization of 1-trichloromethyl-1,2,3,4-tetrahydro-beta-carboline: a biologically relevant neurotoxin? Eur J Pharmacol 442(1\u20132):1\u201316. \nhttps:\/\/doi.org\/10.1016\/S0014-2999(02)01308-0","journal-title":"Eur J Pharmacol"},{"issue":"12","key":"830_CR15","doi-asserted-by":"publisher","first-page":"2792","DOI":"10.1002\/jnr.21725","volume":"86","author":"M Liu","year":"2008","unstructured":"Liu M, Hunter R, Nguyen XV, Kim HC, Bing G (2008) Microsomal epoxide hydrolase deletion enhances tyrosine hydroxylase phosphorylation in mice after MPTP treatment. J Neurosci Res 86(12):2792\u20132801. \nhttps:\/\/doi.org\/10.1002\/jnr.21725","journal-title":"J Neurosci Res"},{"key":"830_CR16","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.freeradbiomed.2015.03.031","volume":"84","author":"EJ Shin","year":"2015","unstructured":"Shin EJ, Jeong JH, Chung CK, Kim DJ, Wie MB, Park ES, Chung YH, Nam Y et al (2015) Ceruloplasmin is an endogenous protectant against kainate neurotoxicity. Free Radic Biol Med 84:355\u2013372. \nhttps:\/\/doi.org\/10.1016\/j.freeradbiomed.2015.03.031","journal-title":"Free Radic Biol Med"},{"issue":"2","key":"830_CR17","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.neuint.2009.10.005","volume":"56","author":"BD Jung","year":"2010","unstructured":"Jung BD, Shin EJ, Nguyen XK, Jin CH, Bach JH, Park SJ, Nah SY, Wie MB et al (2010) Potentiation of methamphetamine neurotoxicity by intrastriatal lipopolysaccharide administration. Neurochem Int 56(2):229\u2013244. \nhttps:\/\/doi.org\/10.1016\/j.neuint.2009.10.005","journal-title":"Neurochem Int"},{"issue":"3","key":"830_CR18","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1007\/s12035-013-8617-1","volume":"49","author":"EJ Shin","year":"2014","unstructured":"Shin EJ, Shin SW, Nguyen TT, Park DH, Wie MB, Jang CG et al (2014) Ginsenoside Re rescues methamphetamine-induced oxidative damage, mitochondrial dysfunction, microglial activation, and dopaminergic degeneration by inhibiting the protein kinase C\u03b4 gene. Mol Neurobiol 49(3):1400\u20131421. \nhttps:\/\/doi.org\/10.1007\/s12035-013-8617-1","journal-title":"Mol Neurobiol"},{"issue":"6","key":"830_CR19","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1016\/j.cellsig.2013.02.017","volume":"25","author":"BK Kim","year":"2013","unstructured":"Kim BK, Tran HY, Shin EJ, Lee C, Chung YH, Jeong JH, Bach JH, Kim WK et al (2013) IL-6 attenuates trimethyltin-induced cognitive dysfunction via activation of JAK2\/STAT3, M1 mAChR and ERK signaling network. Cell Signal 25(6):1348\u20131360. \nhttps:\/\/doi.org\/10.1016\/j.cellsig.2013.02.017","journal-title":"Cell Signal"},{"issue":"2","key":"830_CR20","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/S0378-4347(96)00255-1","volume":"687","author":"G Bringmann","year":"1996","unstructured":"Bringmann G, Friedrich H, Birner G, Koob M, Sontag KH, Heim C, Kolasiewicz W, F\u00e4hr S et al (1996) Endogenous alkaloids in man. XXVI. Determination of the dopaminergic neurotoxin 1-trichloromethyl-1,2,3,4-tetrahydro-beta-carboline (TaClo) in biological samples using gas chromatography with selected ion monitoring. J Chromatogr B Biomed Appl 687(2):337\u2013348. \nhttps:\/\/doi.org\/10.1016\/S0378-4347(96)00255-1","journal-title":"J Chromatogr B Biomed Appl"},{"issue":"1","key":"830_CR21","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1006\/abio.1999.4088","volume":"270","author":"G Bringmann","year":"1999","unstructured":"Bringmann G, God R, F\u00e4hr S, Feineis D, Fornadi K, Fornadi F (1999) Identification of the dopaminergic neurotoxin 1-trichloromethyl-1,2, 3,4-tetrahydro-beta-carboline in human blood after intake of the hypnotic chloral hydrate. Anal Biochem 270(1):167\u2013175. \nhttps:\/\/doi.org\/10.1006\/abio.1999.4088","journal-title":"Anal Biochem"},{"issue":"2","key":"830_CR22","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S1570-0232(01)00589-X","volume":"767","author":"G Bringmann","year":"2002","unstructured":"Bringmann G, M\u00fcnchbach M, Feineis D, Messer K, Diem S, Herderich M, Clement HW, Stichel-Gunkel C et al (2002) Endogenous alkaloids in man. XXXVIII. \u201cChiral\u201d and \u201cachiral\u201d determination of the neurotoxin TaClo (1-trichloromethyl-1,2,3,4-tetrahydro-beta-carboline) from blood and urine samples by high-performance liquid chromatography-electrospray ionization tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 767(2):321\u2013332","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"issue":"9","key":"830_CR23","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1002\/ardp.19903230903","volume":"323","author":"G Bringmann","year":"1990","unstructured":"Bringmann G, Hille A (1990) Endogenous alkaloids in man, VII: 1-trichloromethyl-1,2,3,4-tetrahydro-\u03b2-carbolin\u2014a potential chloral-derived indol alkaloid in man. Arch Pharm (Weinheim) 323(9):567\u2013569. \nhttps:\/\/doi.org\/10.1002\/ardp.19903230903","journal-title":"Arch Pharm (Weinheim)"},{"issue":"4","key":"830_CR24","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1016\/j.cmet.2015.08.003","volume":"22","author":"MF Fernandes","year":"2015","unstructured":"Fernandes MF, Matthys D, Hryhorczuk C, Sharma S, Mogra S, Alquier T, Fulton S (2015) Leptin suppresses the rewarding effects of running via STAT3 signaling in dopamine neurons. Cell Metab 22(4):741\u2013749. \nhttps:\/\/doi.org\/10.1016\/j.cmet.2015.08.003","journal-title":"Cell Metab"},{"issue":"4","key":"830_CR25","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-delta delta C(T)) method. Methods 25(4):402\u2013408. \nhttps:\/\/doi.org\/10.1006\/meth.2001.1262","journal-title":"Methods"},{"issue":"1","key":"830_CR26","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.molbrainres.2004.11.018","volume":"134","author":"JD Jaumotte","year":"2005","unstructured":"Jaumotte JD, Zigmond MJ (2005) Dopaminergic innervation of forebrain by ventral mesencephalon in organotypic slice co-cultures: effects of GDNF. Brain Res Mol Brain Res 134(1):139\u2013146. \nhttps:\/\/doi.org\/10.1016\/j.molbrainres.2004.11.018","journal-title":"Brain Res Mol Brain Res"},{"issue":"4","key":"830_CR27","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1016\/0306-4522(95)00405-X","volume":"70","author":"D Plenz","year":"1996","unstructured":"Plenz D, Aertsen A (1996) Neural dynamics in cortex-striatum co-cultures\u2014II. Spatiotemporal characteristics of neuronal activity. Neuroscience 70(4):893\u2013924. \nhttps:\/\/doi.org\/10.1016\/0306-4522(95)00405-X","journal-title":"Neuroscience"},{"issue":"3","key":"830_CR28","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1006\/taap.2002.9421","volume":"182","author":"PG Forkert","year":"2002","unstructured":"Forkert PG, Lash LH, Nadeau V, Tardif R, Simmonds A (2002) Metabolism and toxicity of trichloroethylene in epididymis and testis. Toxicol Appl Pharmacol 182(3):244\u2013254. \nhttps:\/\/doi.org\/10.1006\/taap.2002.9421","journal-title":"Toxicol Appl Pharmacol"},{"issue":"Suppl 2","key":"830_CR29","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1289\/ehp.00108s2159","volume":"108","author":"CS Scott","year":"2000","unstructured":"Scott CS, Cogliano VJ (2000) Trichloroethylene and cancer: epidemiologic evidence. Environ Health Perspect 108(Suppl 2):159\u2013160. \nhttps:\/\/doi.org\/10.1289\/ehp.00108s2159","journal-title":"Environ Health Perspect"},{"key":"830_CR30","first-page":"235","volume":"46","author":"G Bringmann","year":"1995","unstructured":"Bringmann G, God R, Feineis D, Wesemann W, Riederer P, Rausch WD, Reichmann H, Sontag KH (1995b) The TaClo concept: 1-trichloromethyl-1,2,3,4-tetrahydro-beta-carboline (TaClo), a new toxin for dopaminergic neurons. J Neural Transm Suppl 46:235\u2013244","journal-title":"J Neural Transm Suppl"},{"issue":"1","key":"830_CR31","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1002\/jnr.20412","volume":"80","author":"M D\u2019Astous","year":"2005","unstructured":"D\u2019Astous M, Morissette M, Callier S, Di Paolo T (2005) Regulation of striatal preproenkephalin mRNA levels in MPTP-lesioned mice treated with estradiol. J Neurosci Res 80(1):138\u2013144. \nhttps:\/\/doi.org\/10.1002\/jnr.20412","journal-title":"J Neurosci Res"},{"issue":"5","key":"830_CR32","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1111\/j.1460-9568.2009.06657.x","volume":"29","author":"N Schintu","year":"2009","unstructured":"Schintu N, Frau L, Ibba M, Caboni P, Garau A, Carboni E, Carta AR (2009) PPAR-gamma-mediated neuroprotection in a chronic mouse model of Parkinson\u2019s disease. Eur J Neurosci 29(5):954\u2013963. \nhttps:\/\/doi.org\/10.1111\/j.1460-9568.2009.06657.x","journal-title":"Eur J Neurosci"},{"issue":"1","key":"830_CR33","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1186\/s12906-017-1731-2","volume":"17","author":"S Ahn","year":"2017","unstructured":"Ahn S, Song TJ, Park SU, Jeon S, Kim J, Oh JY, Jang J, Hong S et al (2017) Effects of a combination treatment of KD5040 and (L)-dopa in a mouse model of Parkinson\u2019s disease. BMC Complement Altern Med 17(1):220. \nhttps:\/\/doi.org\/10.1186\/s12906-017-1731-2","journal-title":"BMC Complement Altern Med"},{"issue":"2","key":"830_CR34","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/0306-4522(94)00606-6","volume":"66","author":"AP Nisbet","year":"1995","unstructured":"Nisbet AP, Foster OJ, Kingsbury A, Eve DJ, Daniel SE, Marsden CD, Lees AJ (1995) Preproenkephalin and preprotachykinin messenger RNA expression in normal human basal ganglia and in Parkinson\u2019s disease. Neuroscience 66(2):361\u2013376. \nhttps:\/\/doi.org\/10.1016\/0306-4522(94)00606-6","journal-title":"Neuroscience"},{"issue":"3","key":"830_CR35","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/1055-8330(95)90015-2","volume":"4","author":"V Jackson-Lewis","year":"1995","unstructured":"Jackson-Lewis V, Jakowec M, Burke RE, Przedborski S (1995) Time course and morphology of dopaminergic neuronal death caused by the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Neurodegeneration 4(3):257\u2013269. \nhttps:\/\/doi.org\/10.1016\/1055-8330(95)90015-2","journal-title":"Neurodegeneration"},{"issue":"2","key":"830_CR36","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1111\/j.1471-4159.1992.tb09789.x","volume":"58","author":"MW Cleeter","year":"1992","unstructured":"Cleeter MW, Cooper JM, Schapira AH (1992) Irreversible inhibition of mitochondrial complex I by 1-methyl-4-phenylpyridinium: evidence for free radical involvement. J Neurochem 58(2):786\u2013789. \nhttps:\/\/doi.org\/10.1111\/j.1471-4159.1992.tb09789.x","journal-title":"J Neurochem"},{"issue":"2","key":"830_CR37","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/0361-9230(88)90240-7","volume":"21","author":"E Sundstr\u00f6m","year":"1988","unstructured":"Sundstr\u00f6m E, Luthman J, Goldstein M, Jonsson G (1988) Time course of MPTP-induced degeneration of the nigrostriatal dopamine system in C57 BL\/6 mice. Brain Res Bull 21(2):257\u2013263. \nhttps:\/\/doi.org\/10.1016\/0361-9230(88)90240-7","journal-title":"Brain Res Bull"},{"issue":"2","key":"830_CR38","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/0006-8993(91)90835-J","volume":"553","author":"LS Carman","year":"1991","unstructured":"Carman LS, Gage FH, Shults CW (1991) Partial lesion of the substantia nigra: relation between extent of lesion and rotational behavior. Brain Res 553(2):275\u2013283. \nhttps:\/\/doi.org\/10.1016\/0006-8993(91)90835-J","journal-title":"Brain Res"},{"issue":"2","key":"830_CR39","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/0006-8993(89)90597-0","volume":"494","author":"DA Perese","year":"1989","unstructured":"Perese DA, Ulman J, Viola J, Ewing SE, Bankiewicz KS (1989) A 6-hydroxydopamine-induced selective parkinsonian rat model. Brain Res 494(2):285\u2013293. \nhttps:\/\/doi.org\/10.1016\/0006-8993(89)90597-0","journal-title":"Brain Res"},{"issue":"2","key":"830_CR40","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/0306-4522(94)90605-X","volume":"59","author":"H Sauer","year":"1994","unstructured":"Sauer H, Oertel WH (1994) Progressive degeneration of nigrostriatal dopamine neurons following intrastriatal terminal lesions with 6-hydroxydopamine: a combined retrograde tracing and immunocytochemical study in the rat. Neuroscience 59(2):401\u2013415. \nhttps:\/\/doi.org\/10.1016\/0306-4522(94)90605-X","journal-title":"Neuroscience"},{"issue":"1","key":"830_CR41","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/0014-2999(68)90164-7","volume":"5","author":"U Ungerstedt","year":"1968","unstructured":"Ungerstedt U (1968) 6-Hydroxy-dopamine induced degeneration of central monoamine neurons. Eur J Pharmacol 5(1):107\u2013110. \nhttps:\/\/doi.org\/10.1016\/0014-2999(68)90164-7","journal-title":"Eur J Pharmacol"},{"issue":"2","key":"830_CR42","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1006\/exnr.2002.7891","volume":"175","author":"R Deumens","year":"2002","unstructured":"Deumens R, Blokland A, Prickaerts J (2002) Modeling Parkinson\u2019s disease in rats: an evaluation of 6-OHDA lesions of the nigrostriatal pathway. Exp Neurol 175(2):303\u2013317. \nhttps:\/\/doi.org\/10.1006\/exnr.2002.7891","journal-title":"Exp Neurol"},{"issue":"3","key":"830_CR43","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1074\/jbc.C100560200","volume":"277","author":"AB Manning-Bog","year":"2002","unstructured":"Manning-Bog AB, McCormack AL, Li J, Uversky VN, Fink AL, Di Monte DA (2002) The herbicide paraquat causes up-regulation and aggregation of alpha-synuclein in mice: paraquat and alpha-synuclein. J Biol Chem 277(3):1641\u20131644. \nhttps:\/\/doi.org\/10.1074\/jbc.C100560200","journal-title":"J Biol Chem"},{"issue":"22","key":"830_CR44","doi-asserted-by":"publisher","first-page":"12760","DOI":"10.1073\/pnas.96.22.12760","volume":"96","author":"BJ Day","year":"1999","unstructured":"Day BJ, Patel M, Calavetta L, Chang LY, Stamler JS (1999) A mechanism of paraquat toxicity involving nitric oxide synthase. Proc Natl Acad Sci U S A 96(22):12760\u201312765. \nhttps:\/\/doi.org\/10.1073\/pnas.96.22.12760","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1\u20132","key":"830_CR45","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/S0006-8993(01)02577-X","volume":"906","author":"K Shimizu","year":"2001","unstructured":"Shimizu K, Ohtaki K, Matsubara K, Aoyama K, Uezono T, Saito O, Suno M, Ogawa K et al (2001) Carrier-mediated processes in blood-brain barrier penetration and neural uptake of paraquat. Brain Res 906(1\u20132):135\u2013142. \nhttps:\/\/doi.org\/10.1016\/S0006-8993(01)02577-X","journal-title":"Brain Res"},{"issue":"12","key":"830_CR46","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1038\/81834","volume":"3","author":"R Betarbet","year":"2000","unstructured":"Betarbet R, Sherer TB, MacKenzie G, Garcia-Osuna M, Panov AV, Greenamyre JT (2000) Chronic systemic pesticide exposure reproduces features of Parkinson\u2019s disease. Nat Neurosci 3(12):1301\u20131306. \nhttps:\/\/doi.org\/10.1038\/81834","journal-title":"Nat Neurosci"},{"issue":"10","key":"830_CR47","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/0166-2236(89)90074-X","volume":"12","author":"RL Albin","year":"1989","unstructured":"Albin RL, Young AB, Penney JB (1989) The functional anatomy of basal ganglia disorders. Trends Neurosci 12(10):366\u2013375. \nhttps:\/\/doi.org\/10.1016\/0166-2236(89)90074-X","journal-title":"Trends Neurosci"},{"issue":"16","key":"830_CR48","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1056\/NEJM199810153391607","volume":"339","author":"AE Lang","year":"1998","unstructured":"Lang AE, Lozano AM (1998) Parkinson\u2019s disease. Second of two parts. N Engl J Med 339(16):1130\u20131143. \nhttps:\/\/doi.org\/10.1056\/NEJM199810153391607","journal-title":"N Engl J Med"},{"issue":"12","key":"830_CR49","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1097\/00001756-199407000-00031","volume":"5","author":"WD Hutchison","year":"1994","unstructured":"Hutchison WD, Lozano AM, Davis KD, Saint-Cyr JA, Lang AE, Dostrovsky JO (1994) Differential neuronal activity in segments of globus pallidus in Parkinson\u2019s disease patients. Neuroreport 5(12):1533\u20131537. \nhttps:\/\/doi.org\/10.1097\/00001756-199407000-00031","journal-title":"Neuroreport"},{"issue":"5","key":"830_CR50","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1002\/ana.410420513","volume":"42","author":"WD Hutchinson","year":"1997","unstructured":"Hutchinson WD, Levy R, Dostrovsky JO, Lozano AM, Lang AE (1997) Effects of apomorphine on globus pallidus neurons in parkinsonian patients. Ann Neurol 42(5):767\u2013775. \nhttps:\/\/doi.org\/10.1002\/ana.410420513","journal-title":"Ann Neurol"},{"issue":"2","key":"830_CR51","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/0306-4522(88)90249-7","volume":"25","author":"CM Waters","year":"1988","unstructured":"Waters CM, Peck R, Rossor M, Reynolds GP, Hunt SP (1988) Immunocytochemical studies on the basal ganglia and substantia nigra in Parkinson\u2019s disease and Huntington\u2019s chorea. Neuroscience 25(2):419\u2013438. \nhttps:\/\/doi.org\/10.1016\/0306-4522(88)90249-7","journal-title":"Neuroscience"},{"issue":"4","key":"830_CR52","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/0143-4179(91)90148-C","volume":"18","author":"SP Sivam","year":"1991","unstructured":"Sivam SP (1991) Dopamine dependent decrease in enkephalin and substance P levels in basal ganglia regions of postmortem parkinsonian brains. Neuropeptides 18(4):201\u2013207. \nhttps:\/\/doi.org\/10.1016\/0143-4179(91)90148-C","journal-title":"Neuropeptides"},{"issue":"5","key":"830_CR53","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1111\/j.1471-4159.1987.tb01036.x","volume":"49","author":"SP Sivam","year":"1987","unstructured":"Sivam SP, Breese GR, Krause JE, Napier TC, Mueller RA, Hong JS (1987) Neonatal and adult 6-hydroxydopamine-induced lesions differentially alter tachykinin and enkephalin gene expression. J Neurochem 49(5):1623\u20131633. \nhttps:\/\/doi.org\/10.1111\/j.1471-4159.1987.tb01036.x","journal-title":"J Neurochem"},{"issue":"4986","key":"830_CR54","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1126\/science.2147780","volume":"250","author":"CR Gerfen","year":"1990","unstructured":"Gerfen CR, Engber TM, Mahan LC, Susel Z, Chase TN, Monsma FJ Jr, Sibley DR (1990) D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons. Science 250(4986):1429\u20131432. \nhttps:\/\/doi.org\/10.1126\/science.2147780","journal-title":"Science"},{"issue":"3","key":"830_CR55","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/0169-328X(90)90020-E","volume":"8","author":"SJ Li","year":"1990","unstructured":"Li SJ, Jiang HK, Stachowiak MS, Hudson PM, Owyang V, Nanry K, Tilson HA, Hong JS (1990) Influence of nigrostriatal dopaminergic tone on the biosynthesis of dynorphin and enkephalin in rat striatum. Brain Res Mol Brain Res 8(3):219\u2013225. \nhttps:\/\/doi.org\/10.1016\/0169-328X(90)90020-E","journal-title":"Brain Res Mol Brain Res"},{"issue":"1","key":"830_CR56","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/0006-8993(90)90522-D","volume":"507","author":"HK Jiang","year":"1990","unstructured":"Jiang HK, McGinty JF, Hong JS (1990) Differential modulation of striatonigral dynorphin and enkephalin by dopamine receptor subtypes. Brain Res 507(1):57\u201364. \nhttps:\/\/doi.org\/10.1016\/0006-8993(90)90522-D","journal-title":"Brain Res"},{"issue":"4","key":"830_CR57","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1523\/JNEUROSCI.11-04-01016.1991","volume":"11","author":"CR Gerfen","year":"1991","unstructured":"Gerfen CR, McGinty JF, Young WS 3rd (1991) Dopamine differentially regulates dynorphin, substance P, and enkephalin expression in striatal neurons: in situ hybridization histochemical analysis. J Neurosci 11(4):1016\u20131031","journal-title":"J Neurosci"},{"issue":"1","key":"830_CR58","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/S0969-9961(03)00011-1","volume":"13","author":"W Meissner","year":"2003","unstructured":"Meissner W, Dovero S, Bioulac B, Gross CE, Bezard E (2003) Compensatory regulation of striatal neuropeptide gene expression occurs before changes in metabolic activity of basal ganglia nuclei. Neurobiol Dis 13(1):46\u201354. \nhttps:\/\/doi.org\/10.1016\/S0969-9961(03)00011-1","journal-title":"Neurobiol Dis"},{"issue":"1","key":"830_CR59","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1002\/jnr.24110","volume":"96","author":"F Wedekind","year":"2017","unstructured":"Wedekind F, Oskamp A, Lang M, Hawlitschka A, Zilles K, Wree A, Bauer A (2017) Intrastriatal administration of botulinum neurotoxin A normalizes striatal D(2) R binding and reduces striatal D(1) R binding in male hemiparkinsonian rats. J Neurosci Res 96(1):75\u201386. \nhttps:\/\/doi.org\/10.1002\/jnr.24110","journal-title":"J Neurosci Res"},{"issue":"8","key":"830_CR60","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1007\/s00702-010-0428-1","volume":"117","author":"L Qian","year":"2010","unstructured":"Qian L, Flood PM, Hong JS (2010) Neuroinflammation is a key player in Parkinson\u2019s disease and a prime target for therapy. J Neural Transm (Vienna) 117(8):971\u2013979. \nhttps:\/\/doi.org\/10.1007\/s00702-010-0428-1","journal-title":"J Neural Transm (Vienna)"},{"issue":"6","key":"830_CR61","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1046\/j.1471-4159.2002.00928.x","volume":"81","author":"HM Gao","year":"2002","unstructured":"Gao HM, Jiang J, Wilson B, Zhang W, Hong JS, Liu B (2002) Microglial activation-mediated delayed and progressive degeneration of rat nigral dopaminergic neurons: relevance to Parkinson\u2019s disease. J Neurochem 81(6):1285\u20131297. \nhttps:\/\/doi.org\/10.1046\/j.1471-4159.2002.00928.x","journal-title":"J Neurochem"},{"issue":"8","key":"830_CR62","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/S0165-6147(03)00176-7","volume":"24","author":"HM Gao","year":"2003","unstructured":"Gao HM, Liu B, Zhang W, Hong JS (2003) Novel anti-inflammatory therapy for Parkinson\u2019s disease. Trends Pharmacol Sci 24(8):395\u2013401. \nhttps:\/\/doi.org\/10.1016\/S0165-6147(03)00176-7","journal-title":"Trends Pharmacol Sci"},{"issue":"1","key":"830_CR63","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/nrn2038","volume":"8","author":"ML Block","year":"2007","unstructured":"Block ML, Zecca L, Hong JS (2007) Microglia-mediated neurotoxicity: uncovering the molecular mechanisms. Nat Rev Neurosci 8(1):57\u201369. \nhttps:\/\/doi.org\/10.1038\/nrn2038","journal-title":"Nat Rev Neurosci"},{"issue":"2\u20133","key":"830_CR64","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1007\/s12035-010-8098-4","volume":"41","author":"D Zhang","year":"2010","unstructured":"Zhang D, Hu X, Qian L, O\u2019Callaghan JP, Hong JS (2010) Astrogliosis in CNS pathologies: is there a role for microglia? Mol Neurobiol 41(2\u20133):232\u2013241. \nhttps:\/\/doi.org\/10.1007\/s12035-010-8098-4","journal-title":"Mol Neurobiol"},{"issue":"9","key":"830_CR65","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1016\/j.it.2016.06.006","volume":"37","author":"E Colombo","year":"2016","unstructured":"Colombo E, Farina C (2016) Astrocytes: key regulators of Neuroinflammation. Trends Immunol 37(9):608\u2013620. \nhttps:\/\/doi.org\/10.1016\/j.it.2016.06.006","journal-title":"Trends Immunol"},{"issue":"1","key":"830_CR66","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/S0304-3940(98)00791-5","volume":"257","author":"M Gerlach","year":"1998","unstructured":"Gerlach M, Xiao AY, Heim C, Lan J, God R, Feineis D, Bringmann G, Riederer P et al (1998) 1-Trichloromethyl-1,2,3,4-tetrahydro-beta-carboline increases extracellular serotonin and stimulates hydroxyl radical production in rats. Neurosci Lett 257(1):17\u201320. \nhttps:\/\/doi.org\/10.1016\/S0304-3940(98)00791-5","journal-title":"Neurosci Lett"},{"key":"830_CR67","first-page":"275","volume":"46","author":"C Grote","year":"1995","unstructured":"Grote C, Clement HW, Wesemann W, Bringmann G, Feineis D, Riederer P, Sontag KH (1995) Biochemical lesions of the nigrostriatal system by TaClo (1-trichloromethyl-1,2,3,4-tetrahydro-beta-carboline) and derivatives. J Neural Transm Suppl 46:275\u2013281","journal-title":"J Neural Transm Suppl"},{"issue":"4","key":"830_CR68","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1046\/j.1471-4159.2002.00875.x","volume":"81","author":"F Riederer","year":"2002","unstructured":"Riederer F, Luborzewski A, God R, Bringmann G, Scholz J, Feineis D, Moser A (2002) Modification of tyrosine hydroxylase activity by chloral derived beta-carbolines in vitro. J Neurochem 81(4):814\u2013819. \nhttps:\/\/doi.org\/10.1046\/j.1471-4159.2002.00875.x","journal-title":"J Neurochem"},{"issue":"2","key":"830_CR69","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1111\/j.1471-4159.2004.02710.x","volume":"91","author":"RS Akundi","year":"2004","unstructured":"Akundi RS, Macho A, Mu\u00f1oz E, Lieb K, Bringmann G, Clement HW, H\u00fcll M, Fiebich BL (2004) 1-Trichloromethyl-1,2,3,4-tetrahydro-beta-carboline-induced apoptosis in the human neuroblastoma cell line SK-N-SH. J Neurochem 91(2):263\u2013273. \nhttps:\/\/doi.org\/10.1111\/j.1471-4159.2004.02710.x","journal-title":"J Neurochem"},{"key":"830_CR70","first-page":"255","volume":"46","author":"WD Rausch","year":"1995","unstructured":"Rausch WD, Abdel-mohsen M, Koutsilieri E, Chan WW, Bringmann G (1995) Studies of the potentially endogenous toxin TaClo (1-trichloromethyl-1,2,3,4-tetrahydro-beta-carboline) in neuronal and glial cell cultures. J Neural Transm Suppl 46:255\u2013263","journal-title":"J Neural Transm Suppl"},{"key":"830_CR71","first-page":"265","volume":"46","author":"B Janetzky","year":"1995","unstructured":"Janetzky B, God R, Bringmann G, Reichmann H (1995) 1-Trichloromethyl-1,2,3,4-tetrahydro-beta-carboline, a new inhibitor of complex I. J Neural Transm Suppl 46:265\u2013273","journal-title":"J Neural Transm Suppl"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12035-017-0830-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-017-0830-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-017-0830-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,6,9]],"date-time":"2018-06-09T05:47:37Z","timestamp":1528523257000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12035-017-0830-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12,22]]},"references-count":71,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2018,7]]}},"alternative-id":["830"],"URL":"https:\/\/doi.org\/10.1007\/s12035-017-0830-x","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,12,22]]}}}